These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34780665)

  • 21. Tetrahydrobiopterin synthesis and metabolism is impaired in dystrophin-deficient mdx mice and humans.
    Lindsay A; Kemp B; Larson AA; Baumann CW; McCourt PM; Holm J; Karachunski P; Lowe DA; Ervasti JM
    Acta Physiol (Oxf); 2021 Apr; 231(4):e13627. PubMed ID: 33580591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model.
    Caudal D; François V; Lafoux A; Ledevin M; Anegon I; Le Guiner C; Larcher T; Huchet C
    PLoS One; 2020; 15(3):e0230083. PubMed ID: 32160266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
    van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
    Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.
    Chandrasekharan K; Yoon JH; Xu Y; deVries S; Camboni M; Janssen PM; Varki A; Martin PT
    Sci Transl Med; 2010 Jul; 2(42):42ra54. PubMed ID: 20668298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The unconditioned fear response in dystrophin-deficient mice is associated with adrenal and vascular function.
    Lindsay A; Russell AP
    Sci Rep; 2023 Apr; 13(1):5513. PubMed ID: 37015991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment appears progressive in the mdx mouse.
    Bagdatlioglu E; Porcari P; Greally E; Blamire AM; Straub VW
    Neuromuscul Disord; 2020 May; 30(5):368-388. PubMed ID: 32360405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
    Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA
    PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice.
    Sacco A; Mourkioti F; Tran R; Choi J; Llewellyn M; Kraft P; Shkreli M; Delp S; Pomerantz JH; Artandi SE; Blau HM
    Cell; 2010 Dec; 143(7):1059-71. PubMed ID: 21145579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain function in Duchenne muscular dystrophy.
    Anderson JL; Head SI; Rae C; Morley JW
    Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.
    Tjondrokoesoemo A; Schips TG; Sargent MA; Vanhoutte D; Kanisicak O; Prasad V; Lin SC; Maillet M; Molkentin JD
    J Biol Chem; 2016 May; 291(19):9920-8. PubMed ID: 26966179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
    Li D; Long C; Yue Y; Duan D
    Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.